Publicaciones en colaboración con investigadores/as de Guy's Hospital (27)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  3. Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases

    The Lancet Rheumatology

2022

  1. Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity

    Human Genetics, Vol. 141, Núm. 1, pp. 147-173

  2. Multicentre evaluation of two multiplex PCR platforms for the rapid microbiological investigation of nosocomial pneumonia in UK ICUs: the INHALE WP1 study

    Thorax, Vol. 77, Núm. 12, pp. 1220-1228

2021

  1. Genetic mechanisms of critical illness in COVID-19

    Nature, Vol. 591, Núm. 7848, pp. 92-98

  2. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

2019

  1. Antinuclear Antibody–Negative Systemic Lupus Erythematosus in an International Inception Cohort

    Arthritis Care and Research, Vol. 71, Núm. 7, pp. 893-902

  2. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: A prospective cohort study

    European Heart Journal, Vol. 40, Núm. 39, pp. 3222-3232B

  3. Evaluating the Properties of a Frailty Index and Its Association With Mortality Risk Among Patients With Systemic Lupus Erythematosus

    Arthritis and Rheumatology, Vol. 71, Núm. 8, pp. 1297-1307

  4. Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study

    Arthritis and Rheumatology, Vol. 71, Núm. 2, pp. 281-289

  5. The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry

    European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 5, Núm. 3, pp. 202-207

2016

  1. Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies

    Seminars in Arthritis and Rheumatism, Vol. 45, Núm. 4, pp. 391-399

  2. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 5, pp. 795-810

  3. The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies: Evidence and clinical judgment

    Thrombosis and Haemostasis, Vol. 115, Núm. 2, pp. 285-290

2015

  1. State of the art: Reproduction and pregnancy in rheumatic diseases

    Autoimmunity Reviews, Vol. 14, Núm. 5, pp. 376-386

2014

  1. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

    AIDS, Vol. 28, Núm. 16, pp. 2461-2473

2012

  1. Task force report on the management of thrombosis in antiphospholipid syndrome

    Antiphospholipid Syndrome: Insights and Highlights from the 13Th International Congress on Antiphospholipid Antibodies (Springer US), pp. 167-179

2004

  1. Measuring Systemic Lupus Erythematosus Activity during Pregnancy: Validation of the Lupus Activity Index in Pregnancy Scale

    Arthritis Care and Research, Vol. 51, Núm. 1, pp. 78-82

2002

  1. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: Analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5

    Archives of Internal Medicine, Vol. 162, Núm. 10, pp. 1164-1169